Department of Nutrition, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
AdventHealth Translational Research Institute, Orlando, Florida, USA.
Diabetes Obes Metab. 2023 Mar;25(3):688-699. doi: 10.1111/dom.14911. Epub 2022 Nov 21.
Co-management of weight and glycaemia is critical yet challenging in type 1 diabetes (T1D). We evaluated the effect of a hypocaloric low carbohydrate, hypocaloric moderate low fat, and Mediterranean diet without calorie restriction on weight and glycaemia in young adults with T1D and overweight or obesity.
We implemented a 9-month Sequential, Multiple Assignment, Randomized Trial pilot among adults aged 19-30 years with T1D for ≥1 year and body mass index 27-39.9 kg/m . Re-randomization occurred at 3 and 6 months if the assigned diet was not acceptable or not effective. We report results from the initial 3-month diet period and re-randomization statistics before shutdowns due to COVID-19 for primary [weight, haemoglobin A1c (HbA1c), percentage of time below range <70 mg/dl] and secondary outcomes [body fat percentage, percentage of time in range (70-180 mg/dl), and percentage of time below range <54 mg/dl]. Models adjusted for design, demographic and clinical covariates tested changes in outcomes and diet differences.
Adjusted weight and HbA1c (n = 38) changed by -2.7 kg (95% CI -3.8, -1.5, P < .0001) and -0.91 percentage points (95% CI -1.5, -0.30, P = .005), respectively, while adjusted body fat percentage remained stable, on average (P = .21). Hypoglycaemia indices remained unchanged following adjustment (n = 28, P > .05). Variability in all outcomes, including weight change, was considerable (57.9% were re-randomized primarily due to loss of <2% body weight). No outcomes varied by diet.
Three months of a diet, irrespective of macronutrient distribution or caloric restriction, resulted in weight loss while improving or maintaining HbA1c levels without increasing hypoglycaemia in adults with T1D.
1 型糖尿病(T1D)患者的体重和血糖管理至关重要,但极具挑战。我们评估了低碳水化合物低热量、低碳水化合物中低脂肪和不含热量限制的地中海饮食对超重或肥胖的 T1D 年轻成人的体重和血糖的影响。
我们对年龄在 19-30 岁之间、T1D 患病时间超过 1 年且 BMI 为 27-39.9kg/m²的成年人实施了一项为期 9 个月的连续、多次分配、随机试验。如果分配的饮食不可接受或无效,则在 3 个月和 6 个月时重新随机分组。我们报告了初始 3 个月饮食期的结果以及由于 COVID-19 而关闭前的重新随机分组统计数据,主要结果包括[体重、糖化血红蛋白(HbA1c)、<70mg/dl 范围以下时间百分比]和次要结果[体脂百分比、70-180mg/dl 范围内时间百分比和 <54mg/dl 范围以下时间百分比]。调整设计、人口统计学和临床协变量的模型测试了结果和饮食差异的变化。
调整后的体重和 HbA1c(n=38)分别下降 2.7kg(95%CI:-3.8,-1.5,P<.0001)和 0.91 个百分点(95%CI:-1.5,-0.30,P=0.005),而体脂百分比平均保持稳定(P=0.21)。调整后低血糖指数无变化(n=28,P>.05)。所有结果(包括体重变化)的变异性都很大(57.9%的患者主要由于体重减轻<2%而重新随机分组)。饮食之间无差异。
无论宏量营养素分布或热量限制如何,3 个月的饮食都能减轻体重,同时改善或维持 T1D 成人的 HbA1c 水平,而不会增加低血糖。